Literature DB >> 21494913

Endoscopic pancreatic necrosectomy.

Evan L Fogel1.   

Abstract

Traditionally, patients with symptomatic sterile pancreatic necrosis or infected necrosis have been managed by open surgical debridement and removal of necrotic tissue. Within the last decade, however, reports of endoscopic pancreatic necrosectomy, an alternative minimally invasive approach, have demonstrated high success rates and low mortality rates. This report describes the indications, technique, and study outcome data of the procedure. While our experience with this technique has recently increased, better selection criteria are needed to identify patients who are most suitable for endoscopic therapy.

Entities:  

Mesh:

Year:  2011        PMID: 21494913     DOI: 10.1007/s11605-011-1505-y

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  17 in total

1.  Retroperitoneal endoscopic debridement for infected peripancreatic necrosis.

Authors:  H Seifert; T Wehrmann; T Schmitt; S Zeuzem; W F Caspary
Journal:  Lancet       Date:  2000-08-19       Impact factor: 79.321

2.  Aggressive endoscopic therapy for pancreatic necrosis and pancreatic abscess: a new safe and effective treatment algorithm (videos).

Authors:  Stefan Seewald; Stefan Groth; Salem Omar; Hiroo Imazu; Uwe Seitz; Andreas de Weerth; Roy Soetikno; Yan Zhong; Parupudi V J Sriram; Ryan Ponnudurai; Sanjay Sikka; Frank Thonke; Nib Soehendra
Journal:  Gastrointest Endosc       Date:  2005-07       Impact factor: 9.427

3.  Endoscopic necrosectomy as primary therapy in the management of infected pancreatic necrosis.

Authors:  R M Charnley; R Lochan; H Gray; C B O'Sullivan; J Scott; K E N W Oppong
Journal:  Endoscopy       Date:  2006-09       Impact factor: 10.093

4.  Transluminal endoscopic necrosectomy after acute pancreatitis: a multicentre study with long-term follow-up (the GEPARD Study).

Authors:  H Seifert; M Biermer; W Schmitt; C Jürgensen; U Will; R Gerlach; C Kreitmair; A Meining; T Wehrmann; T Rösch
Journal:  Gut       Date:  2009-03-11       Impact factor: 23.059

5.  Endoscopic necrosectomy as primary treatment for infected peripancreatic fluid collections (with video).

Authors:  Abraham Mathew; Arnab Biswas; Kevin P Meitz
Journal:  Gastrointest Endosc       Date:  2008-10       Impact factor: 9.427

6.  Endoscopic therapy for organized pancreatic necrosis.

Authors:  T H Baron; W G Thaggard; D E Morgan; R J Stanley
Journal:  Gastroenterology       Date:  1996-09       Impact factor: 22.682

7.  Endoscopic transmural debridement of symptomatic organized pancreatic necrosis (with videos).

Authors:  Rogier P Voermans; Mariëlle C Veldkamp; Erik A Rauws; Marco J Bruno; Paul Fockens
Journal:  Gastrointest Endosc       Date:  2007-11       Impact factor: 9.427

8.  Pseudocyst drainage predisposes to infection when pancreatic necrosis is unrecognized.

Authors:  M Hariri; A Slivka; D L Carr-Locke; P A Banks
Journal:  Am J Gastroenterol       Date:  1994-10       Impact factor: 10.864

9.  Peroral endoscopic drainage/debridement of walled-off pancreatic necrosis.

Authors:  Georgios I Papachristou; Naoki Takahashi; Prabhleen Chahal; Michael G Sarr; Todd H Baron
Journal:  Ann Surg       Date:  2007-06       Impact factor: 12.969

10.  A comparison of direct endoscopic necrosectomy with transmural endoscopic drainage for the treatment of walled-off pancreatic necrosis.

Authors:  Timothy B Gardner; Prabhleen Chahal; Georgios I Papachristou; Santhi Swaroop Vege; Bret T Petersen; Christopher J Gostout; Mark D Topazian; Naoki Takahashi; Michael G Sarr; Todd H Baron
Journal:  Gastrointest Endosc       Date:  2009-02-24       Impact factor: 9.427

View more
  2 in total

1.  Update on pathogenesis and clinical management of acute pancreatitis.

Authors:  Dulce M Cruz-Santamaría; Carlos Taxonera; Manuel Giner
Journal:  World J Gastrointest Pathophysiol       Date:  2012-06-15

2.  Hepato-pancreato-biliary emergencies for the acute care surgeon: etiology, diagnosis and treatment.

Authors:  Jean M Butte; Morad Hameed; Chad G Ball
Journal:  World J Emerg Surg       Date:  2015-03-08       Impact factor: 5.469

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.